Copyright
©The Author(s) 2017.
World J Gastroenterol. Jul 28, 2017; 23(28): 5187-5195
Published online Jul 28, 2017. doi: 10.3748/wjg.v23.i28.5187
Published online Jul 28, 2017. doi: 10.3748/wjg.v23.i28.5187
Figure 1 Kaplan-Meier curves of venous thromboembolism-free survival of the whole cohort of gastrointestinal cancer patients.
Comparison between patients stratified on HOMA index (Panel A; HR = 3.17, 95%CI: 1.61-6.23) or fasting blood glucose (Panel B; HR = 4.21, 95%CI: 2.09-8.46).
- Citation: Guadagni F, Riondino S, Formica V, Del Monte G, Morelli AM, Lucchetti J, Spila A, D’Alessandro R, Della-Morte D, Ferroni P, Roselli M. Clinical significance of glycemic parameters on venous thromboembolism risk prediction in gastrointestinal cancer. World J Gastroenterol 2017; 23(28): 5187-5195
- URL: https://www.wjgnet.com/1007-9327/full/v23/i28/5187.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i28.5187